Cardiotomy refers to any surgical incision into the heart muscle itself. The term comes from the Greek kardia (heart) and tomÄ“ (a cutting), and it covers a range of operations from opening a heart chamber to repair a valve or close a septal defect, to making an incision in a ventricle during congenital heart repair. Although the word sounds like a single procedure, it is better understood as a category of surgical access: the moment a surgeon’s blade enters the myocardium, that step is a cardiotomy, regardless of the broader operation being performed. The complications, blood-management challenges, and postoperative syndromes that follow all trace back, in one way or another, to that fundamental act of cutting into a beating organ.
When and Why Surgeons Cut Into the Heart
Most cardiac surgeries do not require an incision directly into the heart. A coronary artery bypass graft, for example, reroutes blood flow around blocked arteries using vessels harvested from the chest wall or leg; the heart itself is not opened. But certain problems demand direct access to structures inside the heart’s chambers. Valve replacement or repair, closure of holes between chambers (septal defects), removal of tumors from inside a chamber, and surgical correction of complex congenital heart defects all require the surgeon to open the heart wall. In congenital repairs such as tetralogy of Fallot, a ventriculotomy (an incision through the ventricular wall) allows the surgeon to widen a narrowed outflow tract and patch a hole between the ventricles.
Advances in preoperative imaging have made some of these incisions more precise. In a proof-of-concept study at a pediatric cardiac center, surgeons used three-dimensional-printed models of patients’ hearts to plan the exact location of the ventriculotomy incision, the shape of the patch, and the placement of conduits before ever entering the operating room.1PubMed Central. Three-dimensional-printed cardiac prototypes aid surgical decision-making and preoperative planning in selected cases of complex congenital heart diseases That kind of planning matters because every millimeter of cardiac incision carries consequences: the more tissue you cut, the larger the scar, and scars in the heart can become the substrate for future electrical problems.
Cardiotomy Suction and the Problem of Shed Blood
When the heart is opened during bypass surgery, blood inevitably spills into the surgical field. That blood is too precious to discard, so cardiac surgical teams use a technique called cardiotomy suction: a vacuum-assisted suction device collects the shed blood from the open chest and feeds it back into the cardiopulmonary bypass (CPB) circuit. The goal is straightforward: conserve the patient’s own blood and reduce the need for transfusions from the blood bank. Most cardiac surgeons use this approach during on-pump surgery, and it has been standard practice for decades.2PubMed Central. Coronary artery surgery: cardiotomy suction or cell salvage?
The trouble is that the blood collected this way is not the same as the blood circulating in your veins. Once blood has been exposed to the open pericardial sac (the membrane surrounding the heart), raw tissue surfaces, and the air in the surgical field, it becomes loaded with debris. Researchers analyzing shed mediastinal blood found more than 300,000 lipid particles per milliliter, with individual particles measuring roughly 10 to 60 micrometers across. The triglyceride profiles of these particles closely matched adipose (fat) tissue in the chest, confirming that the fat came from the surgical wound itself.3PubMed. Characterization of lipid particles in shed mediastinal blood In other words, the suction device is vacuuming up not just stray blood but tiny globules of fat, fragments of tissue, activated immune cells, and clotting debris, then pumping all of it back into the patient’s circulation.
How Recycled Blood Drives Inflammation
Cardiopulmonary bypass already provokes a systemic inflammatory response simply because blood is flowing through plastic tubing and an oxygenator instead of your own vessels. Adding cardiotomy suction blood back into that circuit amplifies the inflammation considerably. A study comparing coronary surgery patients who did and did not have their suction blood returned found that key inflammatory markers rose in both groups after surgery, but the increases were dramatically smaller when suction blood was kept out of the circuit. Peak levels of the inflammatory protein TNF-alpha in the no-retransfusion group were only about 36% of those in the retransfusion group; interleukin-6 peaked at roughly 47%; and the complement fragment C3a, a powerful trigger of further immune activation, peaked at about 75%.4PubMed. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response
Those numbers give a sense of how much extra inflammatory signaling the recycled blood carries. Separate analyses of pericardial suction blood itself have confirmed that it contains significantly elevated concentrations of free hemoglobin (a marker of red blood cell destruction), C3a, interleukin-6, interleukin-8, TNF-alpha, and elevated counts of eosinophils and basophils compared with blood in the patient’s systemic circulation.5PubMed. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving The net effect is a more intense inflammatory state after surgery, which contributes to coagulopathy (impaired clotting), greater blood loss, higher transfusion needs, and a risk of organ dysfunction.6PubMed. Pathophysiological aspects of cardiotomy suction usage
Damage to Blood Cells and Clotting Ability
Beyond inflammation, the mechanical forces involved in suctioning blood through narrow tips and mixing it with air cause direct physical damage to blood cells. Red blood cells burst open (hemolysis), releasing free hemoglobin into the plasma, which itself fuels further inflammation and can injure the kidneys. Platelets are activated and consumed. The resulting blood is measurably less capable of forming stable clots.
Researchers who compared cardiotomy suction blood directly to the patient’s circulating blood found markedly impaired clot stability and reduced levels of fibrinogen and platelets in the suction blood. Even mixing just 10% or 20% suction blood into normal circulating blood was enough to impair platelet aggregation and weaken clot formation.7PubMed. Retransfusion of cardiotomy suction blood impairs haemostasis: ex vivo and in vivo studies This helps explain a clinical paradox: cardiotomy suction is meant to preserve the patient’s blood supply, yet returning that blood can actually increase the amount of blood products the patient ultimately needs because their own clotting system is impaired by what was returned.
Lipid Microemboli and the Brain
One of the most concerning consequences of cardiotomy suction is its role as a source of microemboli, tiny particles that lodge in small blood vessels downstream. Cardiotomy suction has been identified as a major source of lipid microemboli during CPB.8PubMed Central. Cannulae and cell saver design: do they make a difference? During bypass, microemboli can also originate from manipulation of the aorta, decalcification of valves, cavitation within the circuit, and air entrainment, but the fat-laden suction blood is a particularly rich contributor.9Journal of Cardiac Surgery. Cardiac Microemboli During Cardiopulmonary Bypass: Structural Sources, Hemodynamics, and Neurologic Sequelae
Where these particles end up matters. The brain is especially vulnerable because of its dense network of tiny vessels and its enormous oxygen demand. Cognitive decline after cardiac surgery, sometimes called “pumphead” in colloquial terms, has long been observed, and lipid microemboli from suction blood appear to be a meaningful contributor. A study of elderly patients undergoing coronary bypass found that processing shed blood through a continuous-flow cell saver, which washes away lipid debris, resulted in a clinically significant reduction in postoperative cognitive dysfunction compared with returning unprocessed suction blood.10PubMed. Continuous-flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery This was a meaningful finding because it pointed directly to the fat particles, not just the bypass circuit in general, as a driver of cognitive harm.
Not all research on processing suction blood has been as encouraging, though. A separate randomized trial found that processing cardiotomy blood by centrifugation and filtration before reinfusion actually led to greater postoperative bleeding and higher blood product use, without any measurable neurological benefit.11PubMed. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function The processing removed clotting factors along with the debris, creating a different set of problems. This tension, filtering out the bad while preserving the good, remains one of the central engineering challenges in cardiac surgery today.
Engineering Attempts to Tame the Suction Problem
The ideal solution would capture shed blood without destroying its cellular components or introducing contaminants. Several engineering approaches have been tried, none of them perfect.
Cell-saver devices represent the most common alternative to direct cardiotomy suction. These machines collect shed blood, spin it in a centrifuge to separate red blood cells from plasma and debris, wash the red cells with saline, and then return only the cleaned red cells. Cell-saver processing has been shown to significantly reduce concentrations of inflammatory cytokines like TNF-alpha, interleukin-1 receptor antagonist, and interleukin-10 in the returned blood.12European Journal of Cardio-Thoracic Surgery. Cell salvage of cardiotomy suction blood improves the balance between pro- and anti-inflammatory cytokines after cardiac surgery Similarly, patients whose pericardial suction blood was separated rather than directly returned showed lower levels of C-reactive protein, elastase, and interleukin-6 after surgery.13PubMed. Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass The downside is that the washing step strips out plasma proteins, clotting factors, and platelets along with the contaminants, which can worsen bleeding, as the cardiotomy trial demonstrated.
A different approach targets the suction itself. A device called the Smartsuction system was designed to minimize the mixing of air and blood at the suction tip, since air-blood contact is a primary driver of both hemolysis and lipid embolization. In a randomized trial, patients whose shed blood was collected with the Smartsuction device had significantly lower markers of red blood cell destruction (free plasma hemoglobin and lactate dehydrogenase) both during and after bypass compared with patients managed with a conventional cell-saver system.14PubMed. A novel device for reducing hemolysis provoked by cardiotomy suction during open heart cardiopulmonary bypass surgery Experimental comparisons confirmed that the device avoided the severe blood cell destruction and protein loss associated with standard suction techniques that mix air and blood.15PubMed. Smart suction device for less blood trauma: a comparison with Cell Saver
Another variable is the bypass circuit itself. Heparin-coated circuits, where the interior surfaces of the tubing are bonded with a blood-thinning compound, were developed to reduce the inflammatory response triggered by blood contacting foreign plastic. But pairing a coated circuit with a standard uncoated cardiotomy reservoir may undermine the benefit: one study found that using an uncoated reservoir with a heparin-coated circuit produced higher markers of white blood cell activation and free radical production compared with using a cell saver, suggesting the reservoir was a weak link in the biocompatibility chain.16PubMed. Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin coated cardiopulmonary bypass circuit during coronary revascularization surgery
Post-Cardiotomy Syndrome
The word “cardiotomy” also appears in an entirely different clinical context: post-cardiotomy syndrome, more commonly grouped under the umbrella term post-cardiac injury syndrome (PCIS). This is not about the bypass circuit or blood management at all. Instead, it describes an inflammatory reaction that develops days to weeks after cardiac surgery, cardiac trauma, or even a heart attack. The hallmark is pericarditis, inflammation of the sac surrounding the heart, often accompanied by fluid accumulation around the heart (pericardial effusion) and sometimes around the lungs (pleural effusion).17PubMed Central. Evaluation and Management of Post-Cardiotomy Syndrome
The exact cause is still debated. The leading theory is that the initial surgical injury to the pericardium and myocardium releases cellular contents that the immune system treats as foreign. In some patients, the damaged mesothelial cells lining the pericardium and any blood that leaks into the pericardial and pleural spaces may trigger the production of autoantibodies. These antibodies deposit as immune complexes in the lining tissues, driving a delayed inflammatory reaction that can flare weeks after the original surgery.18European Journal of Cardio-Thoracic Surgery. Post-pericardiotomy syndrome: insights into neglected postoperative issues Symptoms include chest pain that worsens with deep breathing or lying flat, low-grade fever, and fatigue. Most cases respond to anti-inflammatory medications like colchicine or nonsteroidal anti-inflammatory drugs, but severe cases with large effusions can require drainage.
Post-cardiotomy syndrome is often underdiagnosed because its symptoms overlap with normal postoperative discomfort. A patient who has just had open-heart surgery expects to have chest pain and fatigue; the distinguishing feature of post-cardiotomy syndrome is that these symptoms either appear for the first time several weeks after surgery or worsen after an initial period of improvement. It is not dangerous in most cases, but an unrecognized pericardial effusion that keeps growing can progress to cardiac tamponade, where the fluid compresses the heart and impairs its ability to fill, which is a surgical emergency.
Post-Cardiotomy Cardiogenic Shock
At the most severe end of post-cardiotomy complications is cardiogenic shock: the heart simply cannot pump enough blood to sustain the body’s organs after surgery. Post-cardiotomy cardiogenic shock (PCCS) is defined as persistent low cardiac output that either prevents the patient from being weaned off the bypass machine at the end of the operation or develops shortly afterward despite aggressive medical treatment.19PubMed Central. Mechanical Circulatory Support in Special Settings It occurs in roughly 1% of cardiac surgery patients, which sounds small until you consider how many cardiac operations are performed worldwide each year.20PubMed Central. Long-term survival and major outcomes in post-cardiotomy extracorporeal membrane oxygenation for adult patients in cardiogenic shock
When PCCS occurs, the treatment escalation is rapid. If drugs that stimulate the heart (inotropes and vasopressors) fail, the team may place the patient on extracorporeal membrane oxygenation (ECMO), a temporary form of mechanical circulatory support that essentially takes over the pumping and oxygenation functions of the heart and lungs. ECMO in this setting is a bridge: a bridge to recovery if the heart can be expected to regain function, or a bridge to a more durable device or heart transplant if it cannot. Survival rates for patients who require ECMO after cardiac surgery remain sobering, though outcomes have improved with better patient selection and earlier initiation of support.
Arrhythmias After Cardiotomy in Congenital Heart Repair
When a cardiotomy is performed as part of congenital heart repair, particularly in conditions like tetralogy of Fallot, the surgical scar itself can become an electrical problem years or even decades later. The mechanism involves slowly conducting tissue channels, called isthmuses, that form between the scar, the native anatomy, and normal myocardium. These isthmuses can support re-entrant electrical circuits that cause ventricular tachycardia, a dangerous fast heart rhythm originating in the lower chambers.21Circulation: Arrhythmia and Electrophysiology. Arrhythmias in Repaired Tetralogy of Fallot: A Scientific Statement From the American Heart Association
The interaction between the surgical scar and ongoing ventricular remodeling (the gradual changes in heart size and shape that happen over a lifetime of altered blood flow) creates a substrate for these arrhythmias that may not become apparent for many years. This is one reason why adults who had congenital heart surgery as children require lifelong cardiac follow-up. The ventriculotomy scar from a repair done at age two can become the source of life-threatening arrhythmias at age thirty-five. Modern surgical techniques try to minimize the size and location of the ventriculotomy, and catheter-based ablation procedures can map and destroy the abnormal electrical pathways when arrhythmias develop, but the fundamental challenge of creating scar in the heart remains.
How Minimally Invasive Approaches Change the Picture
One way to reduce the complications associated with cardiotomy and open-heart surgery is to avoid the full open approach when possible. Minimally invasive coronary artery bypass grafting, performed through smaller incisions without opening the entire sternum, has shown meaningful benefits in reducing some of the downstream problems. A comparative study found that patients who underwent minimally invasive bypass had significantly lower postoperative drainage at every measured time point, needed no red blood cell transfusions compared with a median of two units in the open group, and required no fresh frozen plasma compared with a median of two and a half units in the open group.22PubMed Central. Enhanced Recovery and Reduced Complications with Minimally Invasive Coronary Artery Bypass Grafting Compared to Open Sternotomy
These reductions in blood loss and transfusion reflect a smaller surgical wound, less tissue trauma, and often a shorter or avoided period on cardiopulmonary bypass, all of which shrink the inflammatory cascade and the need for cardiotomy suction. Minimally invasive techniques are not suitable for every patient or every type of cardiac problem; complex multi-vessel disease or operations requiring direct access to multiple heart chambers still demand a full sternotomy and, frequently, a cardiotomy. But the trend toward smaller incisions and reduced bypass time is driven in part by a growing understanding of just how much biological harm the conventional approach inflicts, even when the surgery itself is technically successful.